58 related articles for article (PubMed ID: 25198660)
41. mRNA vaccine for treating pancreatic cancer.
Bird L
Nat Rev Immunol; 2023 Jul; 23(7):413. PubMed ID: 37268820
[No Abstract] [Full Text] [Related]
42. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay].
Chuluyan E; Davio C; Dusetti N; Fraunhoffer N; Garcia MN; Garona J; González B; Gottardo F; Grasso D; Iovanna J; Kohan G; Lada PE; Mazza O; Monte M; Papademetrio D; Pasqualini ME; Sahores A; Santofimia P; Yaneff A
Medicina (B Aires); 2023; 83(4):650-652. PubMed ID: 37582144
[No Abstract] [Full Text] [Related]
43. Research on the epigenetic modification of pancreatic cancer vaccine.
Cao W; Zhou G; Qiu J; Xu L; Ding X; Zhang H; Zhou X
Hepatogastroenterology; 2014; 61(130):272-7. PubMed ID: 24901123
[TBL] [Abstract][Full Text] [Related]
44. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
45. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
46. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
47. Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.
He YJ; Zhou J; Zhao TF; Hu LS; Gan JY; Deng L; Li Y
Mol Med Rep; 2013 Aug; 8(2):662-8. PubMed ID: 23754615
[TBL] [Abstract][Full Text] [Related]
48. Epigenetically modified pancreatic carcinoma PANC-1 cells can act as cancer vaccine to enhance antitumor immune response in mice.
Tao Y; Lin F; Li T; Xie J; Shen C; Zhu Z
Oncol Res; 2013; 21(6):307-16. PubMed ID: 25198660
[TBL] [Abstract][Full Text] [Related]
49. [Comprehensive analysis of disease-related glycosylation, leading to glyco-therapy].
Miyoshi E; Fujii H; Shinzaki S; Tanemura M; Kamada Y
Seikagaku; 2017 Apr; 89(2):264-8. PubMed ID: 29624994
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
